The KEGG pathway enrichment analysis produced 158 enrichment results with P-value < 0.05 (Figure 1C), significantly enriched to PI3K-Akt, apoptosis, and other pathways, which may be the key pathways for QJSB treatment of leukopenia. The gene discussed is AKT1; the disease is Decreased total leukocyte count.